Gillian Hawker

Upon completing her residency and fellowship, Hawker joined U of T's Faculty of Medicine in 1993 as a clinician-scientist at Women's College Hospital (WCH).^[3] She eventually became the director of WCH's osteoporosis research program, where she focused on osteoporosis (OA).^[4] One of her studies into OA included developing alternatives to hormone replacement for bone loss during menopause.^[5] She also helped establish one of the first doctoral programs in clinical epidemiology in North America.^[3] In 2003, Hawker was awarded the F.M. Hill Chair in Academic Women's Medicine by WCH and was appointed their chief of medicine two years later.^[6] In this role, Hawker received a five-year Senior Distinguished Research Investigator Award from the Arthritis Society of Canada.^[7] As a result of her research and academic accomplishments, Hawker was the recipient of the Robert Hyland Award for Excellence in Mentorship and Queen Elizabeth II Diamond Jubilee Medal in 2013.^[8]

Following these awards, Hawker was appointed chair of the Department of Medicine at the University of Toronto for a five-year term starting in July 2014.^[9] While serving in this role, she was elected as a fellow of the Canadian Academy of Health Sciences for her work on improving access to care and outcomes for people with osteoarthritis.^[10] Two years later, Hawker was the recipient of the 2017 Canadian Medical Association May Cohen Award for Women Mentors.^[11]

During the COVID-19 pandemic, Hawker was awarded a Clinical Research Award from the Osteoarthritis Research Society International.^[12]

• Gillian Hawker publications indexed by Google Scholar